Translational research
towards better health


17/10/2018 - Research

A new IGTP spin-off company will develop gene therapy to treat neurodegenerative diseases

Biointaxis, the new spin-off company of the IGTP, was formerly set up recently. The company is the fruit of research led by Dr Antoni Matilla-Dueñas together with Dr Ivelisse Sánchez of the Neurogenetics Group of the IGTP and has been created to increase translational research leading to treatments and new genomic technologies for minority neurological diseases with genetic causes.  The first project the company is undertaking is the development of a genetic therapy for Friedreich's Ataxia.

11/10/2018 - Research

Overview on recommendations on alcohol consumption for patients with liver disease

Dr Daniel Fuster of the Addiction Unit of the Internal Medicine Service at the Germans Trias i Pujol University Hospital and Research Institute (IGTP) and the Universitat Autònoma de Barcelona has co-authored a landmark review article on alcohol use in patients with chronic liver disease with Dr Jeffrey H Samet of Boston Medical Center and University School of Medicine.  The article has been published in the New England Journal of Medicine.


Research in Figures


Principal Investigators


Active projects


Publications with IF


Research Groups


Patent family applications


Active clinical trials


IGTP Corporate Video

See our video here

GCAT Project

50,000 volunteers participating in one biomedical research project to enable researchers to answer vital questions about our health and improve treatments